Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Shuro, Yoshida"'
Autor:
Noriaki Kawano, Yamada Kyohei, Hiroaki Miyoshi, Noriaki Yoshida, Kouichi Ohshima, Fumiko Arakawa, Kazutaka Nakashima, Takuro Kameda, Yasunori Kogure, Yuta Ito, Shuro Yoshida, Takuro Kuriyama, Takashi Nakaike, Taro Tochigi, Ken Takigawa, Kiyoshi Yamashita, Atsushi Toyofuku, Tatsuya Manabe, Atsushi Doi, Soushi Terasaka, Kouske Marutsuka, Hidenobu Ochiai, Ikuo Kikuchi, Yasuo Mori, Keisuke Kataoka, Tomoharu Yoshizumi, Junji Yamauchi, Yoshihisa Yamano, Kazuya Shimoda
Publikováno v:
Renal Replacement Therapy, Vol 9, Iss 1, Pp 1-17 (2023)
Abstract Backgrounds Therefore, reports on the risk of HTLV-1-related diseases in organ transplantation have increased in recent years, and the management of HTLV in renal transplantation remains a challenge. Patients and methods We retrospectively a
Externí odkaz:
https://doaj.org/article/db83b28a408246b89cb019124a3a59df
Autor:
Shuro Yoshida, Yuichiro Semba, Shuichiro Takashima, Masanori Kadowaki, Ken Takase, Takahiro Maeda, Koichi Akashi, Hiromi Iwasaki
Publikováno v:
Case Reports in Hematology, Vol 2024 (2024)
According to the 2016 World Health Organization classification, a germline DEAD-box helicase 41 gene (DDX41) mutation with myeloid neoplasms has been newly classified. The clinical course of acute myeloid leukemia (AML) with a germline DDX41 mutation
Externí odkaz:
https://doaj.org/article/fd1a677775424891b22aa927dbdaa25f
Autor:
Noriaki, Kawano, Shunou, Nakamura, Kousuke, Mochida, Shuro, Yoshida, Takuro, Kuriyama, Takashi, Nakaike, Tomonori, Shimokawa, Taro, Tochigi, Kiyoshi, Yamashita, Koichi, Mashiba, Ikuo, Kikuchi, Aina, Takarabe, Sayaka, Moriguchi, Yasuo, Mori, Katsuto, Takenaka, Kazuya, Shimoda, Hidenobu, Ochiai, Masahiro, Amano
Publikováno v:
Internal Medicine. 61:2771-2774
Secondary malignancies that develop after allogeneic-hematopoietic stem cell transplantation (allo-HSCT) have become serious issues. A 47-year-old man who developed acute myeloid leukemia in 2009 and subsequently underwent allo-HSCT twice: in 2009 an
Autor:
Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Soji Morishita, Shuichi Shirane, Tadaaki Inano, Chiho Furuya, Michiaki Koike, Masaaki Noguchi, Kensuke Usuki, Motoaki Shiratsuchi, Kei Nakajima, Eiichi Ohtsuka, Hiroaki Tanaka, Eri Kawata, Mika Nakamae, Yasunori Ueda, Yasuo Aota, Yasumasa Sugita, Shin Ohara, Satoshi Yamasaki, Kohsuke Asagoe, Shuro Yoshida, Jun Yamanouchi, Sayaka Suzuki, Toshinori Kondo, Yuji Kanisawa, Kohtaro Toyama, Hiromi Omura, Daisuke Mizuchi, Sumio Sakamaki, Miki Ando, Norio Komatsu
Publikováno v:
International Journal of Hematology.
Autor:
Takeshi Sugio, Koji Kato, Shuro Yoshida, Noriyuki Saito, Ichiro Kawano, Hideho Henzan, Toshihiro Miyamoto, Koichi Akashi, Tetsuya Eto
Publikováno v:
Japanese Journal of Transplantation and Cellular Therapy. 11:64-71
Autor:
Miho Kikuta, Masumi Shikita, Shoko Watanabe, Miki Bann, Mitsuko Mori, Kiyoshi Suematsu, Yayoi Matsuo, Shuro Yoshida, Tetsuya Eto
Publikováno v:
Japanese Journal of Transplantation and Cellular Therapy. 11:108-113
Autor:
Shuro Yoshida, Hideho Henzan, Toshiyuki Ueno, Takuya Shimakawa, Yayoi Matsuo, Takuro Kuriyama, Noriyuki Saito, Ichiro Kawano, Akihiko Numata, Ken Takase, Tadafumi lino, Tetsuya Eto
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 12, Iss 2 (2018)
Background: The prognosis of allogeneic hematopoietic stem cell transplantation (HSCT) for non-remission hematological malignant diseases is usually unfavorable. The most uncontrollable factor is residual disease or relapse. To overcome this problem,
Externí odkaz:
https://doaj.org/article/1597b8035e474e7ba6505d39f231e13a
Autor:
Takahiro Fukuda, Yoshiko Atsuta, Makoto Onizuka, Tadakazu Kondo, Tatsuo Ichinohe, Fumihiko Kimura, Yukiyasu Ozawa, Yuta Katayama, Sachiko Seo, Koichi Miyamura, Shinichi Kako, Keitaro Matsuo, Yoshinobu Kanda, Naoyuki Uchida, Shuro Yoshida, Junya Kanda, Yoshiaki Usui, Nobuhiro Tsukada, Shunichi Kato, Aiko Igarashi
Publikováno v:
Bone Marrow Transplantation. 56:2410-2422
Impact of donor age considering HLA disparity on hematopoietic cell transplantation (HCT) outcomes has not been fully evaluated. We evaluated 8486 patients who received unrelated bone marrow transplantation (UR-BMT) from 8/8 or 7/8 HLA-matched donors
Autor:
Noriaki Kawano, Hidemi Shimonodan, Yuri Nagahiro, Shuro Yoshida, Takuro Kuriyama, Ken Takigawa, Taro Tochigi, Takashi Nakaike, Shigeyoshi Makino, Kiyoshi Yamashita, Kousuke Marutsuka, Hidenobu Ochiai, Yasuo Mori, Kazuya Shimoda, Kouichi Ohshima, Koichi Mashiba, Ikuo Kikuchi
Publikováno v:
Journal of Clinical & Experimental Hematopathology; 2023, Vol. 63 Issue 2, p73-82, 10p
Autor:
Shinichi Kako, Takahiro Fukuda, Kazuhiro Ikegame, Yuho Najima, Satoshi Kaito, Masatsugu Tanaka, Tatsuo Ichinohe, Junji Tanaka, Yuma Noguchi, Masashi Sawa, Yoshiko Inoue, Yukiyasu Ozawa, Kaito Harada, Shuichi Ota, Shuro Yoshida, Yoshiko Atsuta
Publikováno v:
Bone Marrow Transplantation. 55:1337-1346
There are few reports on allogeneic hematopoietic stem cell transplantation (allo-HSCT) for adult B-cell acute lymphoblastic leukemia (B-ALL) harboring t(1;19)(q23;p13.3). We used nationwide registry data of Japan for 2003–2016 to evaluate transpla